Latest KFF Health News Stories
Parto en tiempos de adicción: flamante mamá se preocupa por mantenerse sobria
La epidural, que se utiliza para aliviar el dolor del trabajo de parto, puede ser un desafío para mamás que fueron adictas a los opioides.
Childbirth In The Age Of Addiction: New Mom Worries About Maintaining Sobriety
For mothers in recovery from opioid addiction, narcotic pain relief during and after delivery can put sobriety at risk.
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
Píldoras de aceite de pescado y de vitamina D no protegen contra el cáncer o males cardíacos
Los investigadores definieron los males cardíacos graves como el índice combinado de ataques cardíacos, apoplejía y muertes relacionadas con el corazón.
Podcast: KHN’s ‘What The Health?’ Split Decision On Health Care
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico discuss the Trump administration’s new birth control coverage rules and the potential impact of the midterm election results on health policy.
House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
Heart Drug Spotlights Troubling Trends In Drug Marketing
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Republicans’ Preexisting Political Problem
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Stephanie Armour of The Wall Street Journal and Joanne Kenen of Politico discuss how protections for people with preexisting conditions have become a top issue in the elections, Trump administration efforts to make prescription drug prices more public and the start of Medicare’s annual open-enrollment period. Plus, Rovner interviews California Attorney General Xavier Becerra.
Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus
Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
TV Ads Must Trumpet Drug Prices, Trump Administration Says. Pharma Tries A Plan B.
Drug pricing is a top issue in the run-up to the midterm elections.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Falling Premiums And Rising Political Tensions
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the Trump administration’s announcement that average premium prices are falling on the Obamacare marketplaces, the effort by Senate Democrats to reverse rules on short-term health insurance and the focus on protections for people with preexisting conditions in the run-up to midterm elections.
No More Secrets: Congress Bans Pharmacist ‘Gag Orders’ On Drug Prices
Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.
Black Market For Suboxone Gives Some A Glimpse Of Recovery
Addiction experts argue that buprenorphine, which drug users buy on the street, actually saves lives because it is used in place of more dangerous substances, like heroin and fentanyl.
In The Battle To Control Drug Costs, Old Patent Laws Get New Life
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
